methionyl-leucyl-phenylalanine has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallati, H; Müller, R; Obrecht, JP; Obrist, R; Schmidli, J | 1 |
1 trial(s) available for methionyl-leucyl-phenylalanine and Malignant Melanoma
| Article | Year |
|---|---|
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Blood Cell Count; Chemotaxis; Female; Humans; Kidney; Liver; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine | 1991 |